Cancer Care Fund
What Is It?
The Cancer Care Fund is a one-time financial assistance scheme to alleviate the financial burden of newly-diagnosed cancer patients from low or middle income families within the first 6 months of diagnosis.
Who Can Apply?
- Singaporeans or Permanent Residents (there are exceptions for non-residents whose parent, spouse, or child are Singaporeans or Permanent Residents)
- Patients diagnosed with cancer within 6 months of the date of application
- Patients who meet the income requirements of the Community Health Assist Scheme (CHAS)
Funding Assistance
Blue Health Assist card holders with a per capita monthly income of less than $1,100 will receive $1,000.
Orange Health Assist card holders with a per capita monthly income of less than $1,800 will receive $500.
Documents Required
- NRIC
- Application forms duly completed and signed
- CHAS card OR Public Assistance OR Special Grant Card
- Permanent Residents and non-residents without CHAS should complete the income declaration form
- Medical memo or certificate stating clearly the date of diagnosis
- Bank book or bank statement (for those opting for GIRO mode of payment)
How To Apply?
The necessary application forms may be found at the link. Please approach your doctor or medical social worker to complete and submit your application forms. Alternatively, you may contact us for more information.
Welfare Aid Fund
What Is It?
The Welfare Aid fund provides temporary financial assistance and/or medical supplies to enhance the well-being of needy cancer patients. Medical supplies include the supply of milk, diapers, medical dressings, stoma bags and other medical equipment.
Welfare aid mitigates the financial strain endured by patients and their families, which may arise from unemployment, loss of income, and high treatment costs. Funding may be accessed through healthcare professionals or medical social workers from various hospitals, hospices, and voluntary welfare organisations in Singapore.
Who Can Apply?
- Singaporeans or Permanent Residents (there are exceptions for non-Resident applicants whose parents/spouse/children are Singaporeans or Permanent Residents)
- Patients with a per capita income of less than $1,100
- Patients and immediate household with limited household savings
- Patients who meet the means-test criteria administered by SCS
Funding Assistance
Funding amounts will vary according to the successful applicant's healthcare and financial needs.
Documents Required
- Copy of NRIC (front and back) of patient and immediate family members staying in the same household
- The most recent:
- bank statement or passbook entry; or
- payslip or income tax assessment form; or
- 15 month CPF transaction history statement; or
- Cash investment Statement (if applicable)
- Medical memo or certificate
- Documents on assistance received from other organisations.
How To Apply?
Please approach your doctor or medical social worker to complete and submit your application forms. Alternatively, you may contact us for more information.
Cancer Treatment Fund
What Is It?
This fund provides financial assistance to needy cancer patients to subsidise part of their cancer treatment costs. More than 4,200 patients have been assisted through the disbursement of over $14.5 million in cancer treatment subsidies since 2005.Cancer patients are referred to the Society by their healthcare professionals or medical social workers from various restructured hospitals in Singapore.
SCS Patient Access Programme
SCS has tied up with various pharmaceutical companies to help patients with treatment.
For more info email: welfare@singaporecancersociety.org.sg
- SCS–Takeda Partnership
Treatment drug and type of cancers and indications
Adcetris (Brentuximab) – Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systematic Anaplastic Large Cell Lymphoma (sALACL)
- SCS–Merck Partnership
Treatment drug and type of cancers and indications
Erbitux (Cetuximab) – EGFR-expressing, RAS wild-type Mets Colorectal Cancer, SCC of the Head and Neck
- SCS–Novartis Partnership
Treatment drug and type of cancers and indications
Jakavi (Ruxolitinib) – Disease-related splenomegaly and/or symptoms in Myelofibrosis (MF). For Polycythemia Vera (PV) patients who are resistant or intolerant of hydroxyurea
Tasigna (Nilotinib) – Newly diagnosed, chronic and accelerated phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML)
Zykadia (Ceritinib) – Anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)
Afinitor (Everolimus) – For HR+/HER2- advanced breast cancer in combination with exemestane in postmenopausal; progressive neuroendocrine tumors of pancreatic origin (PNET); advanced renal cell carcinoma (RCC) who has progressed on VEGF-targeted therapy; non-functional neuroendocrine tumours of gastrointestinal or lung origin (NETs); tuberous sclerosis complex (TSC-SEGA and TSC-AML)
- SCS–MSD Partnership
The SCS–MSD Enhanced PAP on Keytruda (Pembrolizumab) 200mg per treatment cycles applies only after 1st tier funding on KeytrudaPAP at restructured hospitals
Treatment drug and type of cancers and indications
Keytruda (Pembrolizumab) - Treatment of patients with unresectable or metastatic melanoma; metastatic non-small cell lung carcinoma (NSCLC) PD-L1 ≥50% tumor proportion score (TPS) with no EGFR or ALK genomic tumor aberrations; metastatic non-squamous NSCLC, with no EGFR or ALK genomic tumor aberrations; locally advanced or metastatic NSCLC PD-L1 ≥1% TPS and who has received platinum-containing chemotherapy; refractory classical Hodgkin Lymphoma (cHL); locally advanced or metastatic urothelial carcinoma (UC) PD-L1 ≥10% combined positive score (CPS) and who is not eligible for cisplatin-containing chemotherapy; locally advanced or metastatic urothelial carcinoma who have received prior platinum-containing chemotherapy.
Who Can Apply?
- Singaporeans or Permanent Residents (there are exceptions for non-residents whose parent, spouse, or child are Singaporeans or Permanent Residents)
- Patients must be subsidised
- Patients who meet the medical and means-test criteria administered by SCS
Funding Assistance
Successful applicants will receive subsidies for the approved drug(s) or treatment(s) of up to 100% or $6,000 per cycle/month, whichever is lower. The subsidy is limited to a maximum of $50,000 per person.
Documents Required
- Copy of NRIC (front and back) of patient and immediate family members staying in the same household
- The most recent:
- bank statement or passbook entry; or
- payslip or income tax assessment form; or
- 15 month CPF transaction history statement; or
- Cash investment Statement (if applicable)
- Patient referral form by treating physician
- MediFund certificate (if applicable)
How To Apply?
The necessary application forms may be found at the link. Please approach your doctor or medical social worker to complete and submit your application forms. Alternatively, you may contact us for more information.
Education Financial Assistance Scheme
What Is It?
This scheme was established in 2009 to offer temporary financial assistance to school-going children whose families have been impacted by cancer.
Who Can Apply?
- Recipient of SCS financial assistance
- Singaporeans/Permanent Residents or students whose parents are Singaporeans/Permanent Residents
- Full-time students from a mainstream primary or secondary school, junior college (JC), institute of technical education (ITE), polytechnic, or university
- Students who are not recipients of any other education-related assistance schemes such as bursaries, scholarships, study grants, or sponsorships from the Ministry of Education or any school or organisation in the current academic year.
Funding Assistance
School Allowance (per month)
Primary level: $60
Secondary level: $95
JC/ITE level: $120
Bursary Award (one-off payment)
Polytechnic: $1,800
University: $2,500
Documents Required
- Birth certificate or NRIC
- Student card
- Applicant's or parent's bank account book displaying name and account number
- Completed application form and endorsement by the child's school/education institution
